Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST‐segment elevation myocardial infarction treated by primary percutaneous coronary intervention

BACKGROUND: Previous studies suggested that adiponectin (APN) could ameliorate ischemia/reperfusion injury and endothelial dysfunction in patients with acute myocardial infarction. However, the relationship between serum APN level and coronary flow after primary percutaneous coronary intervention (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Siwen, Li, Hongwei, Shen, Xuhua, Liu, Ruifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595347/
https://www.ncbi.nlm.nih.gov/pubmed/30779470
http://dx.doi.org/10.1002/jcla.22864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595347/
https://www.ncbi.nlm.nih.gov/pubmed/30779470
http://dx.doi.org/10.1002/jcla.22864

Ejemplares similares